Do you have type one diabetes? Have you experienced low blood sugar? If you have T1DM, are using insulin, and have a CGM, you may be able to participate in a research study to see if an oral pill used with your current medications may help to lower the risk of hypoglycemia. Compensation provided.

The study aims to use a special chemical called [11C]UCB-J to measure the connections between brain cells and how these may be different between people with and without diabetes.

The purpose of this study is to learn if a study medication called semaglutide (known as Ozempic) improves blood sugar control in people treated with dialysis.

Fuel for Thought: How do sugar and fat affect each other in the brain? Do you ever wonder what happens in your brain when you eat dessert? And why sugary and fatty foods are so appealing? If so, you may eligible to participate in a research study to understand the impact of sugar and fat on the brain!

If you are healthy and between the ages of 18-55 years, you may be eligible to participate in a research study to find out how sugar affects the brain of individuals who carry certain genetic variants.

Have you or your child been diagnosed with type 1 diabetes during the past 12 months? Are you interested in helping researchers learn more about how to delay or prevent type 1 diabetes or how to treat type 1 diabetes? Join a registry to be notified of future opportunities to participate in type 1 diabetes research!

This study aims to define new forms of diabetes that are not yet understood. Participants will be asked to provide medical and family history and may be asked to have clinical lab testing performed.

We are launching a national Fracture Prevention Program that aims to improve your bone health and reduce the risk of a future broken bone.

The purpose of this research study is to investigate the relationship between sleep brain wave patterns and peripheral glucose (sugar) levels in individuals with and without type 2 diabetes mellitus (T2DM). Participants will undergo continuous glucose monitoring (CGM) using a CGM device for up to two weeks before an in-laboratory sleep study which is part of routine medical care at UNC to examine how sugar levels fluctuate during sleep and how these fluctuations relate to brain wave activity

This is a long-term, open-label extension study of bivamelagon in participants with Hypothalamic Obesity (HO) who have transitioned from the index study, LG-MCCL005. The study will last up to 2 years.